Page 5 of 6
Organic & Biomolecular Chemistry
Journal Name
133.0, 132.3, 130.0, 123.7, 66.0, 60.0, 51.2; HRMS (ESI) calcd (E)-N-(2-(3-Methoxyphenylsulfonyl)ethylidene)mVoierwphAroticllienO-4nl-ine
for C12H16BrN2O3S: 347.0060 (M + H+), found: 347.0067.
1
amine (3n): H NMR (400 MHz, CDCl3)DδOI:71.04.410-379.4/C85O(mB0,1726H5C),
7.35 (s, 1H), 7.15-7.18 (m, 1H), 6.75 (t, J = 5.6 Hz, 1H), 4.02 (d, J
= 5.6 Hz, 2H), 3.87 (s, 3H), 3.77 (t, J = 4.8 Hz, 4H), 2.93 (t, J = 4.8
Hz, 4H); 13C NMR (100 MHz, CDCl3) δ 159.8, 139.6, 130.1, 124.2,
120.5, 120.3, 112.7, 66.0, 60.0, 55.6, 51.2; HRMS (ESI) calcd for
C13H19N2O4S: 299.1060 (M + H+), found: 299.1062.
(E)-N-(2-(4-Fluorophenylsulfonyl)ethylidene)morpholin-4-
amine (3g): H NMR (400 MHz, CDCl3) δ 7.86-7.89 (m, 2H),
7.22-7.27(m, 2H), 6.74 (t, J = 5.6 Hz, 1H), 4.02 (d, J = 5.6 Hz, 2H),
3.78 (t, J = 4.8 Hz, 4H), 2.92 (t, J = 4.8 Hz, 4H); 13C NMR (100
MHz, CDCl3) δ 165.8 (d, JF = 255.2 Hz), 134.4, 131.3 (d, JF = 9.5
1
Hz), 123.9 , 116.3 (d, JF = 22.6 Hz), 66.0, 60.1, 51.2; HRMS (ESI) (E)-N-(2-(Mesitylsulfonyl)ethylidene)morpholin-4-amine (3o):
calcd for C12H16FN2O3S: 278.0860 (M + H+), found: 278.0864.
1H NMR (400 MHz, CDCl3) δ 6.95 (s, 2H), 6.77 (t, J = 5.6 Hz, 1H),
4.02 (d, J = 5.6 Hz, 2H), 3.76 (t, J = 4.8 Hz, 4H), 2.90 (t, J = 4.8 Hz,
4H), 2.64 (s, 6H), 2.30 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
143.3, 140.1, 132.6, 132.0, 124.2, 66.0, 60.0, 51.1, 23.0, 20.9;
HRMS (ESI) calcd for C15H23N2O3S: 311.1424 (M + H+), found:
311.1423.
(E)-Ethyl 4-(2-(Morpholinoimino)ethylsulfonyl)benzoate (3h):
1H NMR (400 MHz, CDCl3) δ8.21 (d, J = 8.4 Hz, 2H), 7.93 (d, J =
8.8 Hz, 2H),6.73 (t, J = 5.6 Hz, 1H), 4.42 (m, 2H), 4.05 (d, J = 5.6
Hz, 2H), 3.76 (t, J = 4.8 Hz, 4H), 2.90 (t, J = 4.8 Hz, 4H), 1.42 (t, J
= 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 164.9, 142.1, 135.2,
130.0, 128.5, 123.5, 65.9, 61.8, 59.9, 51.2, 14.1; HRMS (ESI) (E)-N-(2-(Phenylsulfonyl)ethylidene)piperidin-1-amine (3p):
calcd for C12H16FN2O3S: 341.1166 (M + H+), found: 341.1162.
1H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 7.2 Hz, 2H), 7.65 (t, J =
7.6 Hz, 1H), 7.56 (t, J = 7.2 Hz, 2H), 6.66 (t, J = 5.6 Hz, 1H), 4.03
(d, J = 5.6 Hz, 2H), 2.91 (t, J = 5.6 Hz, 4H),1.58-1.66 (m, 4H),
1.46-1.50 (m, 2H); 13C NMR (100 MHz, CDCl3) δ138.6, 133.6,
128.9, 128.4, 122.0, 60.4, 51.5, 24.6, 23.7; HRMS (ESI) calcd for
C13H19N2O2S: 267.1162(M + H+), found: 267.1167.
(E)-N-(2-(4-Nitrophenylsulfonyl)ethylidene)morpholin-4-
1
amine (3i): H NMR (400 MHz, CDCl3) δ8.42 (d, J = 8.0 Hz, 2H),
8.06 (d, J = 8.0 Hz, 2H),6.74 (t, J = 5.6 Hz, 1H), 4.09 (d, J = 6.0 Hz,
2H), 3.78 (t, J = 4.8 Hz, 4H), 2.92 (t, J = 4.8 Hz, 4H); 13C NMR
(100 MHz, CDCl3) δ144.0, 130.0, 129.3, 124.1, 122.6, 65.9, 59.8,
51.1; HRMS (ESI) calcd for C12H16N3O5S: 314.0805 (M + H+), (E)-1-Methyl-1-phenyl-2-(2-
(phenylsulfonyl)ethylidene)hydrazine (3q): 1H NMR (400 MHz,
found: 314.0797.
CDCl3) δ 7.90 (d, J = 7.2 Hz, 2H), 7.63 (t, J = 7.6 Hz, 1H), 7.54 (t,
J = 8.0 Hz, 2H), 7.22 (t, J = 8.0Hz, 2H), 6.90-6.95 (m, 3H), 6.65 (t,
J = 5.6 Hz, 1H), 4.17 (d, J = 5.6 Hz, 2H), 3.25 (s, 3H); 13C NMR
(100 MHz, CDCl3) δ 147.0, 138.6, 133.6, 129.0, 128.8, 128.4,
121.3, 119.6, 115.6, 60.2, 33.7; HRMS (ESI) calcd for
C15H17N2O2S: 289.1005(M + H+), found: 289.1011.
(E)-N-(2-(o-Tolylsulfonyl)ethylidene)morpholin-4-amine (3j):
1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 8.0 Hz, 1H), 7.52 (t, J =
7.6 Hz, 1H), 7.33-7.37 (m, 2H), 6.71 (t, J = 5.6 Hz, 1H), 4.07 (d, J
= 6.0 Hz, 2H), 3.74 (t, J = 4.8 Hz, 4H), 2.85 (t, J = 4.8 Hz, 4H),
2.71 (s, 3H); 13C NMR (100 MHz, CDCl3) δ138.3, 136.7, 133.7,
132.5, 130.5, 126.2, 124.3, 65.9, 59.3, 51.2, 20.4; HRMS (ESI)
calcd for C13H19N2O3S: 283.1111 (M + H+), found: 283.1113.
1
1-Methoxy-4-(vinylsulfonyl)benzene (7): H NMR (400 MHz,
CDCl3) δ 7.82-7.85 (m, 2H), 7.01-7.04 (m, 2H), 6.65 (m, 1H),
6.40 (d, J = 16.4Hz, 1H), 5.98 (d, J = 10.0Hz, 1H), 3.89 (s, 3H);
13C NMR (100 MHz, CDCl3) δ 139.0, 136.9, 130.1, 126.4, 114.5,
55.6; HRMS (ESI) calcd for C9H11O3S: 199.0423(M + H+), found:
199.0429.
(E)-N-(2-(2-Chlorophenylsulfonyl)ethylidene)morpholin-4-
amine (3k): 1H NMR (400 MHz, CDCl3) δ 8.05 (d, J = 8.0 Hz, 1H),
7.55-7.60 (m, 2H), 7.43-7.48 (m, 1H), 6.69 (t, J = 5.6 Hz, 1H),
4.34 (d, J = 6.0 Hz, 2H), 3.73 (t, J = 4.8 Hz, 4H), 2.84 (t, J = 4.8 Hz,
4H); 13C NMR (100 MHz, CDCl3) δ 134.7, 133.1, 132.0, 131.7,
127.0, 123.6, 65.9, 58.0, 51.1; HRMS (ESI) calcd for
C12H16ClN2O3S: 303.0565 (M + H+), found: 303.0561.
Acknowledgements
(E)-N-(2-(3-Chlorophenylsulfonyl)ethylidene)morpholin-4-
amine (3l): 1H NMR (400 MHz, CDCl3) δ 7.83 (t, J = 2.0 Hz, 1H),
7.75 (d, J = 8.0 Hz, 1H), 7.61-7.64 (m, 1H), 7.51 (t, J = 8.0Hz, 1H),
6.73 (t, J = 5.6 Hz, 1H), 4.03 (d, J = 6.0 Hz, 2H), 3.78 (t, J = 4.8 Hz,
4H), 2.93 (t, J = 4.8 Hz, 4H); 13C NMR (100 MHz, CDCl3) δ 140.0,
135.2, 133.9, 130.3, 128.6, 126.5, 123.4, 66.0, 60.0, 51.2;
HRMS (ESI) calcd for C12H16ClN2O3S: 303.0565 (M + H+), found:
303.0564.
Financial support from National Natural Science Foundation of
China (No. 21372046) and the Science
& Technology
Commission of Shanghai Municipality (No. 12JC1403800) is
gratefully acknowledged.
Notes and references
1
a) Y. Harrak, G. Casula, J. Basset, G. Rosell, S. Plescia, D. Raffa,
M. G. Cusimano, R. Pouplana and M. D. Pujol, J. Med. Chem.,
2010, 53, 6560; b) D. A. Smith and R. M. Jones, Curr. Opin.
Drug Discovery Dev. 2008, 11, 72; c) Y. Noutoshi, M. Ikeda, T.
Saito, H. Osada and K. Shirasu, Front Plant Sci., 2012, 3, 245.
a) M. Bartholow, Top 200 Drugs of 2011. Pharmacy Times.
ly2012/Top-200-Drugs-of-2011, accessed on Jan 9, 2013; b)
(E)-Methyl
3-(2-(Morpholinoimino)ethylsulfonyl)benzoate
(3m): 1H NMR (400 MHz, CDCl3) δ 8.50 (t, J = 1.6 Hz, 1H), 8.30-
8.33 (m, 1H), 8.03-8.06 (m, 1H), 7.66 (t, J = 8.0Hz, 1H), 6.75 (t, J
= 5.6 Hz, 1H), 4.04 (d, J = 5.6 Hz, 2H), 3.97 (s, 3H), 3.76 (t, J =
4.8 Hz, 4H), 2.90 (t, J = 4.8 Hz, 4H); 13C NMR (100 MHz, CDCl3)
δ165.1, 138.9, 134.6, 132.4, 131.2, 129.7, 129.3, 123.6, 66.0,
60.0, 52.6, 51.1; HRMS (ESI) calcd for C14H19N2O5S: 327.1009
(M + H+), found: 327.1019.
2
For
a
list
of
topdrugs
by
year,
see:
pharmaceuticals-poster, accessed on Jan 9, 2013; d) J. Drews,
Science, 2000, 287, 1960.
This journal is © The Royal Society of Chemistry 20xx
J. Name., 2013, 00, 1-3 | 5
Please do not adjust margins